In addition, CSF NEP activity levels correlated positively with CSF Aβ42 levels which was not explained by the presence or absence of ApoE4 [122], suggesting that NEP is involved in both AD and DLB and altered CSF NEP activity may be a useful biomarker for dementia. This evidence concerns the gene APOE and Alzheimer disease.